© 2024 Connecticut Public

FCC Public Inspection Files:
WEDH · WEDN · WEDW · WEDY · WNPR
WPKT · WRLI-FM · WEDW-FM · Public Files Contact
ATSC 3.0 FAQ
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
Cancer Answers is hosted by Dr. Anees Chagpar, Associate Professor of Surgical Oncology and Director of The Breast Center at Smilow Cancer Hospital at Yale-New Haven Hospital, and Dr. Francine Foss, Professor of Medical Oncology. The show features a guest cancer specialist who will share the most recent advances in cancer therapy and respond to listeners questions. Myths, facts and advances in cancer diagnosis and treatment are discussed, with a different focus eachweek. Nationally acclaimed specialists in various types of cancer research, diagnosis, and treatment discuss common misconceptions about the disease and respond to questions from the community.Listeners can submit questions to be answered on the program at canceranswers@yale.edu or by leaving a message at (888) 234-4YCC. As a resource, archived programs from 2006 through the present are available in both audio and written versions on the Yale Cancer Center website.

Alexion Pharmaceuticals To Anchor New Haven Downtown Crossing

http://cptv.vo.llnwd.net/o2/ypmwebcontent/Chion/do%20120619%20Alexion%20+%20New%20Haven.mp3

Alexion Pharmaceuticals Inc. has announced it will move its headquarters to New Haven with up to $51 million in state aid. Governor Malloy announced the move on Tuesday as part of his "First Five" economic development initiative.

For years, New Haven’s Route 34 highway connector separated the Hill neighborhood and Medical district from the downtown area. Alexion Pharmaceuticals’ move is part of a project to knit New Haven back together.

Mayor John DeStefano says four things were key to Alexion Pharmaceuticals’ decision to move to New Haven: the city’s collaborative relationship with Yale University; a thriving city center; a commitment to public education – and  "..a decision we made 12 years ago and stuck with. To close this highway. This highway, in fact, divided the city and subtracted from it."

He’s talking about the Route 34 connector, also known as “the highway to nowhere”. The city plans to take back the land and create an area called Downtown Crossing. Alexion Pharmaceuticals will be the anchor tenant.

Standing beside the highway, DeStefano says this will allow New Haven to expand its footprint to this area of the city. "..not just close the highway. It puts a 426,000 square foot building in the middle with all the attendant street action, people demanding services."

Developer Carter Winstanley says he’s talked for years about bridging the gap between New Haven’s business, government, arts and entertainment, and education centers with the medical district and Hill neighborhood.  

"There are easier sites in and around the city to develop, but there’s a reason why its occurring here. This industry is fundamentally about collaboration and so I think this will kick off more development down through connector."

Work on the project is set to start in early 2013.

Diane Orson is a special correspondent with Connecticut Public. She is a longtime reporter and contributor to National Public Radio. Her stories have been heard on Morning Edition, All Things Considered, Weekend Edition and Here And Now. Diane spent seven years as CT Public Radio's local host for Morning Edition.

Stand up for civility

This news story is funded in large part by Connecticut Public’s Members — listeners, viewers, and readers like you who value fact-based journalism and trustworthy information.

We hope their support inspires you to donate so that we can continue telling stories that inform, educate, and inspire you and your neighbors. As a community-supported public media service, Connecticut Public has relied on donor support for more than 50 years.

Your donation today will allow us to continue this work on your behalf. Give today at any amount and join the 50,000 members who are building a better—and more civil—Connecticut to live, work, and play.

Related Content